Velpanex (Sofosbuvir + Velpatasvir) Tablets
Velpanex (Sofosbuvir 400 mg + Velpatasvir 100 mg) is a fixed-dose combination pill known as a "pan-genotypic" treatment for Hepatitis C.
Manufacturer: Everest Pharmaceuticals. Each pack contains 28 tablets. It is a generic version of Epclusa.
Key Advantage:
This represents the "Gold Standard" in HCV care. One tablet contains two potent antivirals that target the virus at different stages of its life cycle. It is a single-pill regimen, meaning no other drugs are usually required.
✅ Benefit: Cure rates exceeding 98% across all viral genotypes (1–6), offering a simple and highly effective solution.
Indicated for the treatment of chronic Hepatitis C (CHC) in adults:
- 🦠 Pan-Genotypic: Effective for Genotypes 1, 2, 3, 4, 5, and 6.
- 🏥 Liver Status: Used for patients without cirrhosis or with compensated cirrhosis. For decompensated cirrhosis, it is used in combination with Ribavirin.
- 🛡️ Safety: Safe for HIV/HCV co-infected patients.
Packaging: Tablets containing Sofosbuvir 400 mg and Velpatasvir 100 mg.
⚠️ ADMINISTRATION PROTOCOL:
- 💊 Dose: One tablet taken orally once daily.
- 🕒 Consistency: Take at the same time every day.
- 🍲 Usage: Can be taken with or without food. Swallow whole.
- 📅 Duration: The standard course is 12 weeks (3 bottles) for the vast majority of patients.
- Hypersensitivity to active substances.
- ❤️ Drug Interaction: Co-administration with Amiodarone is contraindicated due to severe bradycardia risk.
- Pregnancy and breastfeeding.
- Use with PPIs (Proton Pump Inhibitors) requires caution; do not take simultaneously.
- Use with strong P-gp inducers (e.g., Rifampin, St. John's Wort).
Velpanex is extremely well-tolerated. Adverse events are usually mild:
- 🤯 Neurological: Headache.
- 💤 General: Fatigue.
- 🤢 Gastrointestinal: Nausea.
- Most patients maintain their normal daily routine without significant discomfort.
What Customers Say
No reviews yet
Your review can be the first!